CORECTOGEN

Welcome to the Brand page for “CORECTOGEN”, which is offered here for Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;instruments and apparatus for the administration of gene therapy, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments for the administration of gene therapy products, syringes, scalpels, injectors, catheters, tubes for the administration of gene therapy products;.

Its status is currently believed to be active. Its class is unavailable. “CORECTOGEN” is believed to be currently owned by “Oxford BioMedica plc”.